Velocity Clinical Research, Omaha ( Site 0005) — Omaha, Nebraska

Velocity Clinical Research, Omaha ( Site 0005) is a clinical research site located in Omaha, Nebraska, United States 68134.

Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.

Velocity Clinical Research, Omaha ( Site 0005) has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Healthy.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Velocity Clinical Research, Omaha ( Site 0005)?

Velocity Clinical Research, Omaha ( Site 0005) has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Velocity Clinical Research, Omaha ( Site 0005) conducted?

Velocity Clinical Research, Omaha ( Site 0005) has 2 clinical trials on record, with 2 currently active. Their work covers Healthy.

Is Velocity Clinical Research, Omaha ( Site 0005) accredited by Crixeo Health?

Velocity Clinical Research, Omaha ( Site 0005) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Velocity Clinical Research, Omaha ( Site 0005)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.